Pharmaceuticals in United States

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape

2.1. Market definition
2.2. Market analysis

3.1. Market value

4.1. Geography segmentation

5.1. Market value forecast

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths/weaknesses of leading players?
7.4. What strategies do leading players follow?
7.5. What has been the rationale behind recent M&A activity?
7.6. How does government regulation impact leading players?
7.7. What impact is COVID-19 having on the market?

8.1. Johnson & Johnson
8.2. Pfizer Inc.
8.3. AstraZeneca AB
8.4. Merck & Co., Inc.

9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related research
10.4. About the Author

Table 1: United States pharmaceuticals market value: $ billion, 2015-19
Table 2: United States pharmaceuticals market geography segmentation: $ billion, 2019
Table 3: United States pharmaceuticals market value forecast: $ billion, 2019-24
Table 4: United States pharmaceuticals market share: % share, by value, 2019
Table 5: Johnson & Johnson: key facts
Table 6: Johnson & Johnson: Annual Financial Ratios
Table 7: Johnson & Johnson: Key Employees
Table 8: Johnson & Johnson: Key Employees Continued
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: AstraZeneca AB: key facts
Table 14: AstraZeneca AB: Key Employees
Table 15: Merck & Co., Inc.: key facts
Table 16: Merck & Co., Inc.: Annual Financial Ratios
Table 17: Merck & Co., Inc.: Key Employees
Table 18: Merck & Co., Inc.: Key Employees Continued
Table 19: United States size of population (million), 2015-19
Table 20: United States gdp (constant 2005 prices, $ billion), 2015-19
Table 21: United States gdp (current prices, $ billion), 2015-19
Table 22: United States inflation, 2015-19
Table 23: United States consumer price index (absolute), 2015-19
Table 24: United States exchange rate, 2015-19

Figure 1: United States pharmaceuticals market value: $ billion, 2015-19
Figure 2: United States pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 3: United States pharmaceuticals market value forecast: $ billion, 2019-24
Figure 4: Forces driving competition in the pharmaceuticals market in the United States, 2019
Figure 5: Drivers of buyer power in the pharmaceuticals market in the United States, 2019
Figure 6: Drivers of supplier power in the pharmaceuticals market in the United States, 2019
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2019
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2019
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2019
Figure 10: United States pharmaceuticals market share: % share, by value, 2019